Your browser doesn't support javascript.
loading
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
Horigome, Yuichi; Iino, Masaki; Harazaki, Yoriko; Kobayashi, Takahiro; Handa, Hiroshi; Hiramatsu, Yasushi; Kuroi, Taiga; Tanimoto, Kazuki; Matsue, Kosei; Abe, Masahiro; Ishida, Tadao; Ito, Shigeki; Iwasaki, Hiromi; Kuroda, Junya; Shibayama, Hirohiko; Sunami, Kazutaka; Takamatsu, Hiroyuki; Tamura, Hideto; Hayashi, Toshiaki; Akagi, Kiwamu; Maeda, Takahiro; Yoshida, Takahiro; Mori, Ikuo; Shinozaki, Tomohiro; Iida, Shinsuke.
Afiliação
  • Horigome Y; Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan.
  • Iino M; Department of Hematology, Yamanashi Prefectural Central Hospital, Kofu, Japan.
  • Harazaki Y; Department of Hematology, Miyagi Cancer Center, Natori, Japan.
  • Kobayashi T; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
  • Handa H; Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Hiramatsu Y; Department of Hematology and Oncology, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.
  • Kuroi T; Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan.
  • Tanimoto K; Department of Hematology and Oncology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
  • Matsue K; Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Abe M; Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School, Tokushima, Japan.
  • Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Ito S; Department of Hematology and Oncology, Iwate Medical University Hospital, Iwate, Japan.
  • Iwasaki H; Department of Hematology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Shibayama H; Department of Hematology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Takamatsu H; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
  • Tamura H; Department of Hematology, Nippon Medical School, Tokyo, Japan.
  • Hayashi T; Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Akagi K; Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Ina, Japan.
  • Maeda T; Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Yoshida T; Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Co. Ltd, Tokyo, Japan.
  • Mori I; Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Co. Ltd, Tokyo, Japan.
  • Shinozaki T; Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, 467-8601, Japan. iida@med.nagoya-cu.ac.jp.
Ann Hematol ; 103(2): 475-488, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37695378
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Boro / Fragilidade / Glicina / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Humans País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Boro / Fragilidade / Glicina / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Humans País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article